{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:52:20Z","timestamp":1761562340027},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.gastrohep.2017.12.002","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T18:38:59Z","timestamp":1518547139000},"page":"191-204","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nuevas terapias en la enfermedad celiaca y sus complicaciones"],"prefix":"10.1016","volume":"41","author":[{"given":"Luis","family":"Vaquero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rodr\u00edguez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Jorquera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Vivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2017.12.002_bib0580","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","article-title":"Celiac disease","volume":"357","author":"Green","year":"2007","journal-title":"New Engl J Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0585","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-10-13","article-title":"Spectrum of gluten-related disorders: Consensus on new nomenclature and classification","volume":"10","author":"Sapone","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0590","first-page":"2359","article-title":"[A review of diseases related to the intake of gluten]","volume":"31","author":"Vaquero Ayala","year":"2015","journal-title":"Nutr Hosp."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0595","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4292\/wjgpt.v6.i4.207","article-title":"Age-related differences in celiac disease: Specific characteristics of adult presentation","volume":"6","author":"Vivas","year":"2015","journal-title":"World J Gastrointest Pharmacol Ther."},{"issue":"4 Suppl 1","key":"10.1016\/j.gastrohep.2017.12.002_bib0600","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1053\/j.gastro.2005.02.016","article-title":"The many faces of celiac disease: Clinical presentation of celiac disease in the adult population","volume":"128","author":"Green","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0605","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/j.1572-0241.2008.01977.x","article-title":"Age-related clinical, serological, and histopathological features of celiac disease","volume":"103","author":"Vivas","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0610","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ajg.2013.60","article-title":"Increasing incidence of celiac disease in a North American population","volume":"108","author":"Ludvigsson","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0615","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0025-7753(08)72247-4","article-title":"[Celiac disease]","volume":"131","author":"Rodrigo","year":"2008","journal-title":"Med Clin (Barcelona)"},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0620","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MEG.0000000000000020","article-title":"Coeliac disease screening in first-degree relatives on the basis of biopsy and genetic risk","volume":"26","author":"Vaquero","year":"2014","journal-title":"Eur J Gastroen Hepat."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0625","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/apt.13187","article-title":"Letter: Serum I-FABP as marker for enterocyte damage in first-degree relatives of patients with coeliac disease","volume":"42","author":"Rodriguez-Martin","year":"2015","journal-title":"Aliment Pharm Ther."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0630","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/jgh.13801","article-title":"Coeliac disease and gastrointestinal symptom screening in adult first-degree relatives","volume":"32","author":"Vaquero","year":"2017","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0635","first-page":"65","article-title":"Duodenal mucosa FOXP3 expression in different etiologies of lymphocytic duodenosis","volume":"33","author":"Vaquero","year":"2018","journal-title":"Histol Histopathol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0640","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2010.10","article-title":"Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet","volume":"105","author":"Rubio-Tapia","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0645","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2006.12.006","article-title":"Etiologies and predictors of diagnosis in nonresponsive celiac disease","volume":"5","author":"Leffler","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0650","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/17474124.2014.876360","article-title":"Nutritional consequences of celiac disease and the gluten-free diet","volume":"8","author":"Theethira","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0655","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gastrohep.2011.11.003","article-title":"[Enteropathy-associated intestinal t-cell lymphoma without celiac disease]","volume":"35","author":"Vaquero","year":"2012","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0660","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1056\/NEJMc053129","article-title":"Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma","volume":"354","author":"Vivas","year":"2006","journal-title":"New Engl J Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0665","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1053\/j.gastro.2009.09.008","article-title":"Celiac disease: From pathogenesis to novel therapies","volume":"137","author":"Schuppan","year":"2009","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0670","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(03)13803-2","article-title":"Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease","volume":"362","author":"Maiuri","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0675","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/j.gastro.2005.07.054","article-title":"Unexpected role of surface transglutaminase type II in celiac disease","volume":"129","author":"Maiuri","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0680","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00042737-199905000-00011","article-title":"Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies","volume":"11","author":"Beckett","year":"1999","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0685","doi-asserted-by":"crossref","first-page":"G319","DOI":"10.1152\/ajpgi.00324.2001","article-title":"Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease","volume":"283","author":"Murray","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0690","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cccn.2005.01.029","article-title":"Elevated expression of iNOS mRNA and protein in coeliac disease","volume":"356","author":"Daniels","year":"2005","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0695","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00109-005-0713-x","article-title":"The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages","volume":"84","author":"De Stefano","year":"2006","journal-title":"J Mol Med (Berl)."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0700","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00251-004-0724-8","article-title":"MICA response to gliadin in intestinal mucosa from celiac patients","volume":"56","author":"Martin-Pagola","year":"2004","journal-title":"Immunogenetics."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0705","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.52.2.218","article-title":"Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function","volume":"52","author":"Clemente","year":"2003","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0710","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.febslet.2005.07.066","article-title":"Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins","volume":"579","author":"Sander","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0715","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0720","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0725","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"Hue","year":"2004","journal-title":"Immunity."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0730","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.gastro.2006.06.002","article-title":"A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells","volume":"131","author":"Raki","year":"2006","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0735","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/1521-4141(200106)31:6<1883::AID-IMMU1883>3.0.CO;2-V","article-title":"Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI","volume":"31","author":"Yoshimura","year":"2001","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0740","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1074-7613(02)00272-8","article-title":"Dendritic cell development and survival require distinct NF-kappaB subunits","volume":"16","author":"Ouaaz","year":"2002","journal-title":"Immunity."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0745","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1084\/jem.20061297","article-title":"Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo","volume":"203","author":"Ohteki","year":"2006","journal-title":"J Exp Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0750","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1057","article-title":"Anatomical basis of tolerance and immunity to intestinal antigens","volume":"3","author":"Mowat","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0755","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0198-8859(03)00027-2","article-title":"HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: Results from the European Genetics Cluster on Celiac Disease","volume":"64","author":"Karell","year":"2003","journal-title":"Hum Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0760","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/73200","article-title":"In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope","volume":"6","author":"Anderson","year":"2000","journal-title":"Nat Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0765","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/gast.2002.35381","article-title":"Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues","volume":"123","author":"Arentz-Hansen","year":"2002","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0770","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0016-5085(98)70134-9","article-title":"Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease","volume":"115","author":"Nilsen","year":"1998","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0775","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2249.2006.03239.x","article-title":"Interleukin 18 maintains a long-standing inflammation in coeliac disease patients","volume":"146","author":"Leon","year":"2006","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0780","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0167-5699(99)01536-4","article-title":"T cells orchestrate intestinal mucosal shape and integrity","volume":"20","author":"MacDonald","year":"1999","journal-title":"Immunol Today."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0785","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0105-2896.2005.00294.x","article-title":"Innate and adaptive immunity: The yin and yang of celiac disease","volume":"206","author":"Jabri","year":"2005","journal-title":"Immunol Rev."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0790","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ncpgasthep0582","article-title":"Mechanisms of disease: Immunopathogenesis of celiac disease","volume":"3","author":"Jabri","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0795","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.molimm.2004.12.005","article-title":"Gliadin as a stimulator of innate responses in celiac disease","volume":"42","author":"Londei","year":"2005","journal-title":"Mol Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0800","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.imlet.2005.02.017","article-title":"Adaptive and innate immune responses in celiac disease","volume":"99","author":"Gianfrani","year":"2005","journal-title":"Immunol Lett."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0805","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2005.07.030","article-title":"Celiac disease: Caught between a rock and a hard place","volume":"129","author":"Koning","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0810","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00281-005-0203-9","article-title":"Gluten: A two-edged sword. Immunopathogenesis of celiac disease","volume":"27","author":"Koning","year":"2005","journal-title":"Springer Semin Immunopathol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0815","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2036.2012.05013.x","article-title":"Review article: Coeliac disease, new approaches to therapy","volume":"35","author":"Rashtak","year":"2012","journal-title":"Aliment Pharm Ther."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0820","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2036.2008.03669.x","article-title":"Systematic review: Tolerable amount of gluten for people with coeliac disease","volume":"27","author":"Akobeng","year":"2008","journal-title":"Aliment Pharm Ther."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0825","first-page":"27","article-title":"Are patients with coeliac disease seeking alternative therapies to a gluten-free diet?","volume":"20","author":"Aziz","year":"2011","journal-title":"J Gastrointestin Liver Dis."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0830","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.3748\/wjg.v23.i15.2635","article-title":"Dietary compliance in celiac disease","volume":"23","author":"Freeman","year":"2017","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0835","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.dld.2010.05.005","article-title":"Searching for wheat plants with low toxicity in celiac disease: Between direct toxicity and immunologic activation","volume":"43","author":"Carroccio","year":"2011","journal-title":"Digest Liver Dis."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0840","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-230X-13-92","article-title":"Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease","volume":"13","author":"Zanini","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0845","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1365-2036.2008.03668.x","article-title":"Review article: Future research on coeliac disease \u2014 a position report from the European multistakeholder platform on coeliac disease (CDEUSSA)","volume":"27","author":"Troncone","year":"2008","journal-title":"Aliment Pharm Ther."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0850","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/gut.36.3.375","article-title":"Wheat deficient in gliadins: promising tool for treatment of coeliac disease","volume":"36","author":"Frisoni","year":"1995","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0855","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jada.2009.07.032","article-title":"Psyllium as a substitute for gluten in bread","volume":"109","author":"Zandonadi","year":"2009","journal-title":"J Am Diet Assoc."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-7-1","article-title":"Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes","volume":"7","author":"Van Herpen","year":"2006","journal-title":"BMC Genomics."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0865","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.giec.2012.09.001","article-title":"Nondietary therapies for celiac disease","volume":"22","author":"Mukherjee","year":"2012","journal-title":"Gastrointest Endosc Clin N Am."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0870","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AEM.70.2.1088-1096.2004","article-title":"Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients","volume":"70","author":"Di Cagno","year":"2004","journal-title":"Appl Environ Microbiol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0875","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1128\/AEM.00260-07","article-title":"Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: New perspectives for celiac disease","volume":"73","author":"Rizzello","year":"2007","journal-title":"Appl Environ Microbiol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0880","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00253-003-1539-5","article-title":"Properties and applications of microbial transglutaminase","volume":"64","author":"Yokoyama","year":"2004","journal-title":"Appl Microbiol Biotechnol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0885","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2796.2011.02376.x","article-title":"Novel therapies for coeliac disease","volume":"269","author":"Sollid","year":"2011","journal-title":"J Int Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0890","doi-asserted-by":"crossref","first-page":"G621","DOI":"10.1152\/ajpgi.00034.2006","article-title":"Highly efficient gluten degradation with a newly identified prolyl endoprotease: Implications for celiac disease","volume":"291","author":"Stepniak","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0895","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: Implications for coeliac disease","volume":"57","author":"Mitea","year":"2008","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0900","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-416039-2.00013-6","article-title":"Oral enzyme therapy for celiac sprue","volume":"502","author":"Bethune","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0905","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1542-3565(05)00365-4","article-title":"Low-dose gluten challenge in celiac sprue: Malabsorptive and antibody responses","volume":"3","author":"Pyle","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0910","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2007.05.028","article-title":"Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue","volume":"133","author":"Gass","year":"2007","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2011.08.030","article-title":"Non-dietary therapeutic clinical trials in coeliac disease","volume":"23","author":"Crespo Perez","year":"2012","journal-title":"Eur J Inter Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0920","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"Lahdeaho","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0925","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/bip.21352","article-title":"Interaction of alpha-gliadin with polyanions: Design considerations for sequestrants used in supportive treatment of celiac disease","volume":"93","author":"Liang","year":"2010","journal-title":"Biopolymers."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0930","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.gastro.2008.09.016","article-title":"Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium","volume":"136","author":"Pinier","year":"2009","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0935","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/gut.44.2.212","article-title":"Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine","volume":"44","author":"Warny","year":"1999","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0940","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/17512433.2016.1200463","article-title":"Current and novel therapeutic strategies in celiac disease","volume":"9","author":"Kurada","year":"2016","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0945","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaci.2009.08.006","article-title":"Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial","volume":"125","author":"Bager","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0950","doi-asserted-by":"crossref","first-page":"e17366","DOI":"10.1371\/journal.pone.0017366","article-title":"Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial","volume":"6","author":"Daveson","year":"2011","journal-title":"PloS one."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0955","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2014.07.022","article-title":"Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease","volume":"135","author":"Croese","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0960","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08830185.2011.598978","article-title":"Important lessons derived from animal models of celiac disease","volume":"30","author":"Marietta","year":"2011","journal-title":"Int Rev Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0965","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-3083.2001.00869.x","article-title":"Intranasal administration of one alpha gliadin can downregulate the immune response to whole gliadin in mice","volume":"53","author":"Maurano","year":"2001","journal-title":"Scand J Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0970","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-2478(03)00069-5","article-title":"Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice","volume":"88","author":"Senger","year":"2003","journal-title":"Immunol Lett."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0975","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.4049\/jimmunol.0900233","article-title":"Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells","volume":"182","author":"De Kauwe","year":"2009","journal-title":"J Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0980","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/db05-1593","article-title":"Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives","volume":"55","author":"Sapone","year":"2006","journal-title":"Diabetes."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0985","doi-asserted-by":"crossref","first-page":"C1213","DOI":"10.1152\/ajpcell.00558.2003","article-title":"The tight junction: a multifunctional complex","volume":"286","author":"Schneeberger","year":"2004","journal-title":"Am J Physiol Cell Physiol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0990","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(00)02169-3","article-title":"Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease","volume":"355","author":"Fasano","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib0995","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI119271","article-title":"Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model","volume":"99","author":"Fasano","year":"1997","journal-title":"J Clin Invest."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1000","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.03.023","article-title":"Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3","volume":"135","author":"Lammers","year":"2008","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1005","doi-asserted-by":"crossref","first-page":"16799","DOI":"10.1073\/pnas.0906773106","article-title":"Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2","volume":"106","author":"Tripathi","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: A proof of concept study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment Pharm Ther."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1756283X15616576","article-title":"The potential utility of tight junction regulation in celiac disease: Focus on larazotide acetate","volume":"9","author":"Khaleghi","year":"2016","journal-title":"Therap Adv Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: A randomised placebo-controlled study","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment Pharm Ther."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1025","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge","volume":"107","author":"Leffler","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1030","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: A randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1035","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.2174\/092986707782023343","article-title":"New therapeutic strategies for coeliac disease: Tissue transglutaminase as a target","volume":"14","author":"Esposito","year":"2007","journal-title":"Curr Med Chem."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1040","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I","article-title":"T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase","volume":"31","author":"Molberg","year":"2001","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.chembiol.2005.02.007","article-title":"Chemistry and biology of dihydroisoxazole derivatives: Selective inhibitors of human transglutaminase 2","volume":"12","author":"Choi","year":"2005","journal-title":"Chem Biol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1050","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmc.2007.07.001","article-title":"Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease","volume":"15","author":"Xia","year":"2007","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","article-title":"Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1","volume":"74","author":"Berlin","year":"1993","journal-title":"Cell."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"New Engl J Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"New Engl J Med."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1070","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2011.02.015","article-title":"Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases","volume":"140","author":"Villablanca","year":"2011","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1075","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1021\/bi026020q","article-title":"The CXCR3 binding chemokine IP-10\/CXCL10: Structure and receptor interactions","volume":"41","author":"Booth","year":"2002","journal-title":"Biochemistry."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ajg.2010.450","article-title":"Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease","volume":"106","author":"Di Sabatino","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/labinvest.3700225","article-title":"Matrix metalloproteinase pattern in celiac duodenal mucosa","volume":"85","author":"Ciccocioppo","year":"2005","journal-title":"Lab Invest."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ibd.21038","article-title":"Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study","volume":"16","author":"Reinisch","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.dld.2006.10.017","article-title":"Treatment of life-threatening type I refractory coeliac disease with long-term infliximab","volume":"40","author":"Costantino","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1100","doi-asserted-by":"crossref","first-page":"15849","DOI":"10.1073\/pnas.0908834106","article-title":"Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes","volume":"106","author":"Yokoyama","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1105","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","article-title":"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease","volume":"4","author":"Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/gut.2003.023150","article-title":"Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa","volume":"54","author":"Salvati","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00042737-200110000-00010","article-title":"A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease","volume":"13","author":"Mulder","year":"2001","journal-title":"Eur J Gastroen Hepat."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1120","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1586\/17474124.2015.1033399","article-title":"Celiac disease 2015 update: New therapies","volume":"9","author":"Veeraraghavan","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1125","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T cells","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1130","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","article-title":"Evaluation of Cladribine treatment in refractory celiac disease type II","volume":"17","author":"Tack","year":"2011","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1135","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2010.199","article-title":"Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy","volume":"46","author":"Tack","year":"2011","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1140","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: Retrospective evaluation of single-centre experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1145","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.dld.2007.03.009","article-title":"Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma","volume":"39","author":"Al-Toma","year":"2007","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2017.12.002_bib1150","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/j.1582-4934.2008.00516.x","article-title":"Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool","volume":"12","author":"Garcia-Castro","year":"2008","journal-title":"J Cell Mol Med."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570518300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570518300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T04:23:17Z","timestamp":1530159797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570518300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0210570518300013"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2017.12.002","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuevas terapias en la enfermedad celiaca y sus complicaciones","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}